Nisa Investment Advisors
ALXN

Nisa Investment Advisors’s Alexion Pharmaceuticals ALXN Stock Holding History

Nisa Investment Advisors’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-44,728
Closed -$8.22K – 2371
2021
Q2 		$8.22K Sell
44,728
-63,287
-59% -$10.9M 0.05% 314
2021
Q1 		$16.5K Buy
108,015
+37,129
+52% +$5.74M 0.1% 192
2020
Q4 		$11.1M Sell
70,886
-3,440
-5% -$442K 0.07% 261
2020
Q3 		$8.51M Sell
74,326
-14,521
-16% -$1.57M 0.07% 266
2020
Q2 		$9.97M Buy
88,847
+12,488
+16% +$1.33M 0.09% 212
2020
Q1 		$6.86M Buy
76,359
+46,908
+159% +$4.6M 0.08% 235
2019
Q4 		$3.19M Sell
29,451
-6,974
-19% -$746K 0.03% 499
2019
Q3 		$3.57M Sell
36,425
-17,325
-32% -$1.95M 0.03% 460
2019
Q2 		$7.04M Sell
53,750
-6,665
-11% -$859K 0.07% 287
2019
Q1 		$8.17M Buy
60,415
+4,174
+7% +$519K 0.08% 241
2018
Q4 		$5.48M Buy
56,241
+2,560
+5% +$303K 0.06% 293
2018
Q3 		$7.46M Buy
53,681
+12,616
+31% +$1.58M 0.07% 277
2018
Q2 		$5.1M Buy
41,065
+5,870
+17% +$686K 0.05% 344
2018
Q1 		$3.97M Buy
35,195
+10,030
+40% +$1.2M 0.04% 403
2017
Q4 		$3.01M Sell
25,165
-12,720
-34% -$1.55M 0.03% 486
2017
Q3 		$5.32M Buy
37,885
+8,800
+30% +$1.2M 0.06% 313
2017
Q2 		$3.34M Sell
29,085
-25,120
-46% -$2.92M 0.04% 426
2017
Q1 		$6.57M Buy
54,205
+15,670
+41% +$2.02M 0.08% 265
2016
Q4 		$4.71M Buy
38,535
+12,675
+49% +$1.55M 0.06% 332
2016
Q3 		$3.17M Buy
25,860
+25
+0.1% +$3.22K 0.04% 421
2016
Q2 		$3.02M Sell
25,835
-2,515
-9% -$357K 0.04% 428
2016
Q1 		$3.95M Buy
28,350
+2,150
+8% +$316K 0.06% 345
2015
Q4 		$5M Buy
26,200
+19,800
+309% +$3.46M 0.07% 274
2015
Q3 		$1.02M Buy
6,400
+1,000
+19% +$182K 0.02% 726
2015
Q2 		$976K Sell
5,400
-900
-14% -$155K 0.01% 784
2015
Q1 		$1.09M Sell
6,300
-350
-5% -$63.4K 0.02% 762
2014
Q4 		$1.23M Sell
6,650
-200
-3% -$37.1K 0.02% 714
2014
Q3 		$1.14M Sell
6,850
-300
-4% -$49.3K 0.02% 729
2014
Q2 		$1.12M Buy
7,150
+400
+6% +$63.2K 0.02% 762
2014
Q1 		$1.03M Hold
6,750
– – 0.01% 782
2013
Q4 		$897K Buy
6,750
+3,000
+80% +$360K 0.01% 838
2013
Q3 		$436K Sell
3,750
-100
-3% -$11K 0.01% 1058
2013
Q2 		$355K Buy
+3,850
New +$371K 0.01% 1114

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

Nisa Investment Advisors's ALXN Position: Q3 2021 in Review

Nisa Investment Advisors sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 44,728 shares — an estimated $8.22K sold.

Nisa Investment Advisors first reported a position in ALXN in Q2 2013 and held it in 33 quarters. The position peaked at $11.1M in Q4 2020. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Nisa Investment Advisors reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Nisa Investment Advisors sold 44,728 Alexion Pharmaceuticals shares in Q3 2021, an estimated $8.22K.
  • Nisa Investment Advisors first reported a position in Alexion Pharmaceuticals in Q2 2013 and held it in 33 quarters.
  • Nisa Investment Advisors's Alexion Pharmaceuticals position peaked at $11.1M in Q4 2020.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Nisa Investment Advisors's 13F filing for Q3 2021, filed 18 Oct 2021.